Sisters4Prevention Breast Cancer Stories and Survival
Since my diagnosis fourteen years ago, I have been dedicated to researching lifestyle changes and supporting clinical research to achieve the prevention of breast cancer. My goal is to raise awareness of the need for research funding for the primary prevention of women's cancers and to share information to help those facing this journey. My posts are educational and include my journey with bilateral breast cancer and my year of treatment including a double mastectomy and reconstruction. I have been a breast cancer advocate since 2010 and have served on panels at the department of defense breast cancer funding review programs. My website shares all the information I have collected and verified from long term survivors and medical evidence. I am not a medical professional, simply a teacher who hopes to make a difference by sharing information. I presently serve as one of three breast cancer advocates on the pending clinical trial under the direction of Dr. Vincent Tuohy at the Cleveland clinic to prevent the recurrence of triple negative breast cancer, the most lethal form of the disease began in the Fall of in 2021.I am a graduate of the National Breast Cancer Coalition's Project LEAD and have lobbied Congress for additional funds for prevention clinical trials for breast and ovarian cancers. In 2022, I was invited to be a Komen Advocate in Science. Stay tuned...
Sisters4Prevention Breast Cancer Stories and Survival
Breast Cancer Vaccine Trial to Prevent Recurrence of Triple Negative Breast Cancer Now Recruiting Patients
As many of you know, for the past ten years I have been a passionate advocate for what we dubbed, “The Pink Vaccine.“ This vaccine was developed at the Cleveland Clinic in Ohio under the direction of Dr. Vincent Tuohy at the Learner Research Institute.
For the past four years, I have been honored to serve as a patient advocate for the Phase I clinical trial for Dr. Tuohy’s vaccine. It is with great pleasure and overwhelming excitement, that I can now announce and encourage patients to apply to participate in the Phase I clinical trial. Finally, this vaccine is transitioning from bench to bedside, and will be directed by Dr. Thomas Budd at the Taussig Cancer Center at the Cleveland Clinic.
To participate in this trial, patients must meet the following criteria:
Ø Diagnosed with Triple Negative Breast Cancer
Ø Be Within three years of completing treatment
Ø NED – confirmed by their oncologist in writing to be No Evidence of Disease
Full details of the trial may be found on clinicaltrials.gov:
https://clinicaltrials.gov/ct2/show/NCT04674306?term=Cleveland+Clinic&cond=Triple+Negative+Breast+Cancer&cntry=US&state=US%3AOH&draw=2&rank=1
Those meeting the above criteria for participation may email: CancerAnswer@CCF.org
For more information, you may also visit my website: http://www.Sisters4Prevention.com or email me at Sisters4Prevention@yahoo.com.
I would like to thank everyone who donated or supported me in my advocacy efforts for this vaccine. You have always responded generously with your time and talent. Please know that this milestone in finding a cure for breast cancer by prevention would not have been possible without your love, efforts and support over the last ten years. Now friends the best is yet to come. We can finally test this vaccine and hope to Imagine a World Without Breast Cancer and realize that Prevention is the Cure.
#PinkVaccine #PreventionIsTheCure #BreastCancerVaccine #PreventBreastCancer
#PrimaryPrevention #StopBreastCancer #WorldWithoutBreastCancer